145 related articles for article (PubMed ID: 8875617)
21. Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines.
Siler CA; McGettigan JP; Dietzschold B; Herrine SK; Dubuisson J; Pomerantz RJ; Schnell MJ
Virology; 2002 Jan; 292(1):24-34. PubMed ID: 11878905
[TBL] [Abstract][Full Text] [Related]
22. Murine antibody against E2 can capture hepatitis C virus in vitro.
Ma W; Feng B; Tao Q
Chin Med J (Engl); 2001 Aug; 114(8):860-3. PubMed ID: 11780368
[TBL] [Abstract][Full Text] [Related]
23. Expression and characterization of hepatitis C Virus E2 glycoprotein fused to hepatitis B virus preS1(21-47) fragment in CHO cells.
Wang CL; Zhu LX; Liu J; Zhang ZC; Wang Y; Li GD
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Jul; 34(4):400-4. PubMed ID: 12098759
[TBL] [Abstract][Full Text] [Related]
24. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
[TBL] [Abstract][Full Text] [Related]
25. Systematic analysis of attenuated Coxsackievirus expressing a foreign gene as a viral vaccine vector.
Kim DS; Cho YJ; Kim BG; Lee SH; Nam JH
Vaccine; 2010 Feb; 28(5):1234-40. PubMed ID: 19941986
[TBL] [Abstract][Full Text] [Related]
26. [Induction of antibody to hepatitis C virus E2 antigene can be enhanced by coinjection of interleukin-2 and HCV E2 expression plasmid].
Ma W; Feng B
Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):383-5. PubMed ID: 11798791
[TBL] [Abstract][Full Text] [Related]
27. Presentation of the hydrophilic domains of hepatitis C viral E2 envelope glycoprotein on hepatitis B surface antigen particles.
Lee IH; Kim CH; Ryu WS
J Med Virol; 1996 Oct; 50(2):145-51. PubMed ID: 8915880
[TBL] [Abstract][Full Text] [Related]
28. Expression and self-assembly of HCV structural proteins into virus-like particles and their immunogenicity.
Zhao W; Liao GY; Jiang YJ; Jiang SD
Chin Med J (Engl); 2004 Aug; 117(8):1217-22. PubMed ID: 15361298
[TBL] [Abstract][Full Text] [Related]
29. Morphological identification of hepatitis C virus E1 and E2 envelope glycoproteins on the virion surface using immunogold electron microscopy.
Kaito M; Watanabe S; Tanaka H; Fujita N; Konishi M; Iwasa M; Kobayashi Y; Gabazza EC; Adachi Y; Tsukiyama-Kohara K; Kohara M
Int J Mol Med; 2006 Oct; 18(4):673-8. PubMed ID: 16964422
[TBL] [Abstract][Full Text] [Related]
30. Conformational epitopes detected by cross-reactive antibodies to envelope 2 glycoprotein of the hepatitis C virus.
Nakano I; Fukuda Y; Katano Y; Hayakawa T
J Infect Dis; 1999 Oct; 180(4):1328-33. PubMed ID: 10479166
[TBL] [Abstract][Full Text] [Related]
31. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment.
Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R
J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C virus (HCV): a review of immunological aspects.
Irshad M; Khushboo I; Singh S; Singh S
Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
[TBL] [Abstract][Full Text] [Related]
33. Deletion of N-glycosylation sites of hepatitis C virus envelope protein E1 enhances specific cellular and humoral immune responses.
Liu M; Chen H; Luo F; Li P; Pan Q; Xia B; Qi Z; Ho WZ; Zhang XL
Vaccine; 2007 Sep; 25(36):6572-80. PubMed ID: 17675185
[TBL] [Abstract][Full Text] [Related]
34. Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins in stably transfected CHO cells.
Brazzoli M; Helenius A; Foung SK; Houghton M; Abrignani S; Merola M
Virology; 2005 Feb; 332(1):438-53. PubMed ID: 15661174
[TBL] [Abstract][Full Text] [Related]
35. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
36. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.
Forns X; Payette PJ; Ma X; Satterfield W; Eder G; Mushahwar IK; Govindarajan S; Davis HL; Emerson SU; Purcell RH; Bukh J
Hepatology; 2000 Sep; 32(3):618-25. PubMed ID: 10960458
[TBL] [Abstract][Full Text] [Related]
37. Secretory Expression of Different C-terminal Truncated HCV E1 Proteins in Mammalian Cells and Characterization of the Expressed Products.
Zhu J; Kong YY; Liu J; Zhang ZC; Wang Y; Li GD
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2001; 33(6):634-640. PubMed ID: 12035054
[TBL] [Abstract][Full Text] [Related]
38. Analysis of hepatitis C virus capsid, E1, and E2/NS1 proteins expressed in insect cells.
Lanford RE; Notvall L; Chavez D; White R; Frenzel G; Simonsen C; Kim J
Virology; 1993 Nov; 197(1):225-35. PubMed ID: 8212557
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of hepatitis C virus envelope proteins expressed in E. coli and insect cells for use as tools for antibody screening.
Hüssy P; Faust H; Wagner JC; Schmid G; Mous J; Jacobsen H
J Hepatol; 1997 Jun; 26(6):1179-86. PubMed ID: 9210602
[TBL] [Abstract][Full Text] [Related]
40. [Expression of hepatitis C virus genome].
Nishihara T; Mizuno K; Shikata T
Nihon Rinsho; 1993 Feb; 51(2):323-8. PubMed ID: 7681882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
